Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 1, 2016, Pages 132-142

  Abraham, Hazel Mae A ^a   Wolfson, Leslie ^a   Moscufo, Nicola ^b   Guttmann, Charles R G ^b   Kaplan, Richard F ^a   White, William B ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Ambulatory blood pressure; cerebral small vessel disease (SVD); cognitive function; mobility; systolic hypertension; white matter hyperintensity lesions

Indexed keywords

BIOLOGICAL MARKER; HOMOCYSTEINE; LIPOPROTEIN; VON WILLEBRAND FACTOR;

AGED; AGING; BLOOD PRESSURE; BODY EQUILIBRIUM; BRAIN FUNCTION; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HYPERTENSION; MOBILIZATION; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; WHITE MATTER LESION; BLOOD PRESSURE MONITORING; CEREBRAL SMALL VESSEL DISEASES; CLINICAL STUDY; COMPLICATION; GENETICS; METABOLISM; MICROVASCULATURE; PATHOLOGY; RISK FACTOR; WHITE MATTER;

AGED; AGING; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CEREBRAL SMALL VESSEL DISEASES; CLINICAL STUDIES AS TOPIC; HUMANS; HYPERTENSION; MICROVESSELS; RISK FACTORS; WHITE MATTER;

EID: 84951568899     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.121     Document Type: Review

References (70)

1. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274-1282
2. Yikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R and Tilvis R. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995; 26: 1171-1177
3. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701
4. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005; 112: 900-905
5. Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011; 82: 126-135
6. Marstrand JR, Garde E, Rostrup E, Ring P, Rosenbaum S, Mortensen EL, et al. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 2002; 33: 972-976
7. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-828
8. Wolfson L, Wakefield DB, Moscufo N, Kaplan RF, Hall CB, Schmidt JA, et al. Rapid buildup of brain white matter hyperintensities over 4 years linked to ambulatory blood pressure, mobility, cognition, and depression in old persons. J Gerontol A Biol Sci Med Sci 2013; 68: 1387-1394
9. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005; 128: 2034-2041
10. Zheng JJ, Lord SR, Close JC, Sachdev PS, Wen W, Brodaty H, et al. Brain white matter hyperintensities, executive dysfunction, instability, and falls in older people: a prospective cohort study. J Gerontol A Biol Sci Med Sci 2012; 67: 1085-1091
11. Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-Hayes M, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010; 41: 600-606
12. Kuller LH, Shemanski L, Manolio T, Haan M, Fried L, Bryan N, et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke 1998; 29: 388-398
13. Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, et al. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 2008; 65: 94-100
14. Silvert LC, Howieson DB, Dodge H and Kaye JA. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 2009; 73: 120-125
15. Smith EE, Gurol ME, Eng JA, Engel CR, Nguyen TN and Rosand J. White matter lesions, cognition, and recurrent hemorrahage in lobar intracerebral hemorrhage. Neurology 2004; 63: 1606-1612
16. Dufouil C, Godin O, Chalmers J, Coskun O, MacMahon S, Tzourio-Mazoyer N, et al. Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke 2009; 40: 2219-2221
17. Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, van der Flier WM, et al. Longitudinal cognitive decline in subcortical ischemic vascular disease-the LADIS Study. Cerebrovasc Dis 2009; 27: 384-391
18. Debette S, Bombois S, Bruandet A, Delbeuck X, Lepoittevin S, Delmaire C, et al. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke 2007; 38: 2924-2930
19. Haley AP, Hoth KF, Gunstad J, Paul RH, Jefferson AL, Tate DF, et al. Subjective cognitive complaints relate to white matter hyperintensities and future cognitive decline in patients with cardiovascular disease. Am J Geriatr Psychiatry 2009; 17: 976-985
20. Debette S and Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010; 341: c3666
21. Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008; 70: 935-942
22. SoumaréA, Elbaz A, Zhu Y, Maillard P, Crivello F, Tavernier B, et al. White matter lesions volume and motor performances in the elderly. Ann Neurol 2009; 65: 706-715
23. Carmelli D, DeCarli C, Swan GE, Jack LM, Reed T, Wolf PA, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998; 29: 1177-1181
24. Adib-Samii P, Brice G, Martin RJ and Markus HS. Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke 2010; 41: 630-634
25. Schmidt H, Zeginigg M, Wiltgen M, Freudenberger P, Petrovic K, Cavalieri M, et al. Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease. Brain 2011; 134: 3384-3397
26. Hirose T, Totsune K, Nakashige Y, Metoki H, Kikuya M, Ohkubo T, et al. Influence of adrenomedullin 2/intermedin gene polymorphism on blood pressure, renal function and silent cerebrovascular lesions in Japanese: the Ohasama study. Hypertens Res 2011; 34: 1327-1332
27. Lah JJ and Frishman WH. Adrenomedullin: a vasoactive and natriuretic peptide with therapeutic potential. Heart Dis 2000; 2: 259-265
28. Roh J, Chang CL, Bhalla A, Klein C and Hsu SY. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complex. J Biol Chem 2004; 279: 7264-7274
29. French CR, Seshadri S, Destefano AL, Fornage M, Arnold CR, Gage PJ, et al. Mutation of FOXC1 and PITX2 induces cerebral small-vessel disease. J Clin Invest 2014; 124: 4877-4881
30. Assareh AA, Mather KA, Crawford JD, Wen W, Anstey KJ, Easteal S, et al. Renin-angiotensin system genetic polymorphisms and brain white matter lesions in older Australians. Am J Hypertens 2014; 27: 1191-1198
31. Schmidt R, Schmidt H, Fazekas F, Launer LJ, Niederkorn K, Kapeller P, et al. Angiotensinogen polymorphism M235T, carotid atherosclerosis, and smallvessel disease-related cerebral abnormalities. Hypertension 2001; 38: 110-115
32. Rosenstock J, Cefalu WT, Lapuerta P, Zambrowicz B, Ogbaa I, Banks P, et al. Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of sodium glucose transporters SGLT1 and SGLT2, in Type 2 diabetes on metformin monotherapy. Diabetes Care 2014; 38: 431-438
33. Costacou T, Secrest AM, Ferrell RE and Orchard TJ. Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes. Diab Vasc Dis Res 2014; 11: 335-342
34. Bokura H, Yamaguchi S, Iijima K, Nagai A and Oguro H. Metabolic syndrome is associated with silent ischemic brain lesions. Stroke 2008; 39: 1607-1609
35. Portet F, Brickman AM, Stern Y, Scarmeas N, Muraskin J, Provenzano FA, et al. Metabolic syndrome and localization of white matter hyperintensities in the elderly population. Alzheimers Dement 2012; 8: S88-S95
36. Weinger K, Jacobson AM, Musen G, Lyoo IK, Ryan CM, Jimerson DC, et al. The effects of type 1 diabetes on cerebral white matter. Diabetologia 2008; 51: 417-425
37. Sims RC, Katzel LI, Lefkowitz DM, Siegel EL, Rosenberger WF, Manukyan Z, et al. Association of fasting glucose with subclinical cerebrovascular disease in older adults without Type 2 diabetes. Diabet Med 2014; 31: 691-698
38. van Harten B, Oosterman JM, Potter van Loon BJ, Scheltens P and Weinstein HC. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 2007; 57: 70-74
39. Novak V, Last D, Alsop DC, Abduljalil AM, Hu K, Lepicovsky L, et al. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care 2006; 29: 1529-1534
40. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-483
41. Wright CB, Paik MC, Brown TR, Stabler SP, Allen RH, Sacco RL, et al. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke 2005; 36: 1207-1211
42. Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffrey S, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127: 212-219
43. Han JH, Wong KS, Wang YY, Fu JH, Ding D and Hong Z. Plasma level of sICAM-1 associated with extent of white matter lesion among asymptomatic elderly subjects. Clin Neurol Neurosurg 2009; 111: 847-851
44. Wada M, Nagasawa H, Kurita K, Koyama S, Arawaka S, Kawanami T, et al. Cerebral small vessel disease and C-reactive protein: results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 2008; 264: 43-49
45. Shibata H, Nabika T, Moriyama H, Masuda J and Kobayashi S. Correlation of NO metabolites and 8-isoprostaglandin F2a with periventricular hyperintensity severity. Arterioscler Thromb Vasc Biol 2004; 24: 1659-1663
46. Nagai M, Hoshide S and Kario K. Association of prothrombotic status with markers of cerebral small vessel disease in elderly hypertensive patients. Am J Hypertens 2012; 25: 1088-1094
47. Fukuda H and Kitani M. Cigarette smoking is correlated with the periventricular hyperintensity grade of brain magnetic resonance imaging. Stroke 1996; 27: 645-649
48. Schilling S, Tzourio C, Dufouil C, Zhu Y, Berr C, Alpérovitch A, et al. Plasma lipids and cerebral small vessel disease. Neurology 2014; 83: 1844-1852
49. Manolio TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Gardin JM, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 1994; 25: 318-327
50. Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, Sonni S, et al. Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke 2010; 41: 437-442
51. Dietschy JM and Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol 2001; 12: 105-112
52. Mauch DH, Nägler K, Schumacher S, Göritz C, Müller EC, Otto A, et al. CNS synaptogenesis promoted by gliaderived cholesterol. Science 2001; 294: 1354-1357
53. de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, et al. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 1999; 46: 827-833
54. White WB, Wolfson L, Wakefield DB, Hall CB, Campbell P, Moscufo N, et al. Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Circulation 2011; 124: 2312-2319
55. Verhaaren BF, Vernooij MW, de Boer R, Hofman A, Niessen WJ, van der Lugt A, et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension 2013; 61: 1354-1359
56. Wolfson L. Microalbuminurea as an index of brain microvascular dysfunction. J Neurol Sci 2008; 272: 34-35
57. Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr, et al. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004; 35: 1821-1825
58. Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009; 8: 205-216
59. Benson RR, Guttmann CR, Wei X, Warfield SK, Hall C, Schmidt JA, et al. Older people with impaired mobility have specific loci of periventricular abnormality on MRI. Neurology 2002; 58: 48-55
60. Baloh RW, Yue Q, Socotch TM and Jacobson KM. White matter lesions and disequilibrium in older people. I. Case-control comparison. Arch Neurol 1995; 52: 970-974
61. Sakakibara R, Hattori T, Uchiyama T and Yamanishi T. Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function. J Neurol Neurosurg Psychiatry 1999; 67: 658-660
62. JunquéC, Pujol J, Vendrell P, Bruna O, Jódar M, Ribas JC, et al. Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol 1990; 47: 151-156
63. Kuchel GA, Moscufo N, Guttmann CR, Zeevi N, Wakefield D, Schmidt J, et al. Localization of brain white matter hyperintensities and urinary incontinence in community-dwelling older adults. J Gerontol A Giol Sci Med Sci 2009; 64: 902-909
64. Kaplan RF, Cohen RA, Moscufo N, Guttmann C, Chasman J, Buttaro M, et al. Demographic and biological influences on cognitive reserve. J Clin Exp Neuropsychol 2009; 31: 868-876
65. Moscufo N, Guttmann CR, Meier D, Csapo I, Hildenbrand PG, Healy BC, et al. Brain regional lesion burden and impaired mobility in the elderly. Neurobiol Aging 2011; 32: 646-654
66. Moscufo N, Wolfson L, Meier D, Liguori M, Hildenbrand PG, Wakefield D, et al. Mobility decline in the elderly relates to lesion accrual in the splenium of the corpus callosum. Age (Dordr) 2012; 34: 405-414
67. Campbell P, Ghuman N, Wakefield D, Wolfson L and White WB. Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly. J Hum Hypertens 2010; 24: 749-754
68. White WB, Mansoor GA, Tendler BE and Anwar YA. Nocturnal blood pressure epidemiology, determinants, and effects of antihypertensive therapy. Blood Press Monit 1998; 3: 43-51
69. White WB, Marfatia R, Schmidt J, Wakefield DB, Kaplan RW, Bohannon CB, et al. Intensive versus standard ambulatory blood pressure lowering to prevent functional decline in the elderly (INFINITY). Am Heart J 2013; 165: 258-265
70. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898.